# clm_8ED842A2DCE7

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: revenue  
value: 232,261,000,000 DKK  
valid_from: 2023-12-31  
valid_to: 2024-12-31  
published: 2024-01-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A3B9347CE850  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk revenue: 232,261,000,000 DKK", as of 2023-12-31 (until 2024-12-31). Claim clm_8ED842A2DCE7, https://asof.is/claim/clm_8ED842A2DCE7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/0001628280-24-002635-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:Revenue in 20-F FY2023, filed 2024-01-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/0001628280-24-002635-index.htm (primary, SEC EDGAR 20-F FY2023, published 2024-01-31)

## Supersedes

- [Novo Nordisk](/record/novo-nordisk.md) | revenue | 176,954,000,000 DKK | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_8ED842A2DCE7](/claim/clm_8ED842A2DCE7.md) | [clm_459BEEC0AB43](/claim/clm_459BEEC0AB43.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.